5th Cleaning Validation and Environmental Monitoring
5th Cleaning Validation and Environmental Monitoring Summit Connects Global Pharma Professionals in Amsterdam and Online
Amsterdam, Netherlands | November 11–12, 2026 – The 5th Cleaning Validation and Environmental Monitoring Summit (#Ecleaning 2026), organised by Etapa Pharma, successfully brought together pharmaceutical and biotechnology professionals for two days of expert-led presentations, knowledge exchange, and discussions on the evolving landscape of cleaning validation and environmental monitoring.
Hosted in Amsterdam and accessible online, the hybrid summit connected industry professionals from across the international pharmaceutical community, creating opportunities for both in-person and virtual participants to exchange expertise, explore emerging technologies, and discuss practical approaches to regulatory compliance.
As regulatory expectations continue to evolve and pharmaceutical manufacturing processes become increasingly sophisticated, robust cleaning validation and effective environmental monitoring remain essential pillars of product safety, contamination control, and regulatory compliance.
The fifth edition of #Ecleaning provided an international platform for industry professionals, regulatory experts, and technology providers to explore current challenges, share practical experiences, and discuss innovative approaches shaping the future of pharmaceutical manufacturing.
Addressing the Industry’s Most Pressing Challenges
Across two days of presentations, panel discussions, and professional exchange, the summit explored key developments in cleaning validation and environmental monitoring, with particular attention to risk-based approaches, regulatory expectations, and the practical implementation of compliance strategies.
The programme addressed several critical areas, including:
Risk-Based Cleaning Validation Strategies and Lifecycle Approaches – Exploring modern methodologies for establishing and maintaining robust cleaning validation throughout the product lifecycle, including the justification of acceptance criteria and residue limits.
PDE-Based Acceptance Limits and HBELs in Practice – Examining the application of Permitted Daily Exposure (PDE) and Health-Based Exposure Limits (HBELs) to support effective cross-contamination prevention and analytical method validation.
Microbiological and Endotoxin Control – Discussing strategies for detecting, preventing, and managing microbiological and endotoxin contamination in pharmaceutical manufacturing environments.
Environmental Monitoring Programme Design under EU GMP Annex 1 – Exploring risk-based monitoring approaches, EM-FMECA models, contamination hazard identification, and the practical implementation of revised Annex 1 requirements.
Cleaning Validation in Isolators and HPAPI Facilities – Addressing the challenges of cleaning and contamination control in specialised manufacturing environments, including risk assessment, cleaning methods, and verification strategies.
Inspection Readiness and Regulatory Lessons Learned – Sharing practical experiences and inspection findings to help organisations identify common challenges and strengthen their compliance strategies.
Exploring Innovation: AI, Digitalisation and the Future of Contamination Control:
An important dimension of this year’s programme was the growing role of technology and digital transformation in pharmaceutical manufacturing.
Discussions explored how artificial intelligence and data science can support predictive contamination control by bringing together environmental monitoring, HVAC, BMS, LIMS, and MES data to identify potential risks earlier.
The programme also examined the journey towards data-driven GMP facilities, highlighting the transition from paper-based processes to digital systems and the opportunities this creates for improved data quality, operational efficiency, and informed decision-making.
Other important topics included the role of Pharma 4.0, automated parts washers, online and at-line TOC monitoring, and the integration of cleaning, disinfection, and environmental monitoring strategies within the Contamination Control Strategy (CCS).
These discussions highlighted the importance of combining established validation principles with technological innovation to strengthen manufacturing operations and support continuous improvement.
Connecting Regulatory Expectations with Practical Implementation
A central theme throughout the summit was the importance of translating regulatory requirements into effective, risk-based practices that can be consistently applied across pharmaceutical and biotechnology manufacturing operations.
Through expert presentations and interactive discussions, participants had the opportunity to examine real-world challenges, exchange perspectives, and explore practical solutions supporting more effective cleaning validation and environmental monitoring programmes.
Particular attention was given to the implementation of EU GMP Annex 1, the application of Quality Risk Management principles, the prevention of cross-contamination, and the importance of robust cleaning and disinfection strategies.
Bringing Together the Pharmaceutical Community
Beyond the technical programme, #Ecleaning 2026 provided valuable opportunities for professionals to connect with peers, exchange industry experiences, and establish new professional relationships.
By combining an in-person conference experience in Amsterdam with online participation, the summit enabled a wider international audience to engage with the programme and benefit from the expertise shared throughout the two days.
The summit brought together professionals from across the pharmaceutical and biotechnology industries, including representatives from manufacturing, quality assurance, quality control, validation, microbiology, environmental monitoring, regulatory affairs, and technical operations. The event also provided an opportunity for industry experts, consultants, and technology providers to exchange knowledge and share practical experiences.
These discussions highlighted the importance of cross-functional collaboration in developing effective contamination control strategies and maintaining high standards of pharmaceutical product quality and patient safety.
Thank You to Our Speakers, Participants, and Partners
Etapa Hub would like to extend its sincere appreciation to all speakers who shared their expertise, practical experiences, and valuable industry perspectives throughout the two-day programme.
We are equally grateful to our participants, both in Amsterdam and online, for their active engagement, thoughtful questions, and contributions to the discussions. Their commitment to knowledge sharing and continuous improvement is what makes the #Ecleaning community such a valuable platform for the pharmaceutical industry.
We would also like to thank our sponsors and partners for their support and continued commitment to advancing innovation, compliance, and excellence in pharmaceutical manufacturing.
Looking Ahead: Join Us for the 6th Edition in 2027!
As the pharmaceutical industry continues to navigate evolving regulatory expectations, increasing manufacturing complexity, and the adoption of new technologies, cleaning validation and environmental monitoring will remain fundamental to ensuring product quality and patient safety.
The 5th Cleaning Validation and Environmental Monitoring Summit once again demonstrated the value of bringing together industry expertise, regulatory perspectives, and practical experience to address these challenges.
But the conversation doesn’t stop here!
Etapa Hub is already looking ahead to the 6th Cleaning Validation and Environmental Monitoring Summit in 2027!
We look forward to welcoming the global pharmaceutical community once again for another edition filled with expert insights, practical knowledge, meaningful discussions, and valuable networking opportunities.
Stay connected with Etapa Pharma for upcoming announcements, programme updates, and registration details.
Thank you to everyone who joined us in Amsterdam and online. See you at #Ecleaning 2027!
Speakers
Relative events
For any event assistance please contact
Stay informed. Stay ahead
Subscribe to our newsletter for exclusive pharma event updates, industry insights, and speaker announcements.